Modern Diagnostic Research Centre Ltd vs Sharma East India Hosp And Medical Research Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Modern Diagnostic & Research Centre Ltd is ₹ 60 as of 23 Oct 15:30 . The P/E Ratio of Modern Diagnostic & Research Centre Ltd changed from 15.4 on March 2026 to 15.4 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Sharma East India Hosp and Medical Research Ltd changed from 24.9 on March 2025 to 34.6 on March 2026 . This represents a CAGR of 17.88% over 2 years The Market Cap of Modern Diagnostic & Research Centre Ltd changed from ₹ 80.96 crore on March 2026 to ₹ 80.96 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Sharma East India Hosp and Medical Research Ltd changed from ₹ 24.42 crore on March 2025 to ₹ 33.94 crore on March 2026 . This represents a CAGR of 17.89% over 2 years The revenue of Modern Diagnostic & Research Centre Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sharma East India Hosp and Medical Research Ltd for the Jun '26 is ₹ 10.8 crore as compare to the Mar '26 revenue of ₹ 7.49 crore. This represent the growth of 44.19% The ebitda of Modern Diagnostic & Research Centre Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sharma East India Hosp and Medical Research Ltd for the Jun '26 is ₹ 0.9 crore as compare to the Mar '26 ebitda of ₹ 1.03 crore. This represent the decline of -12.62% The net profit of Modern Diagnostic & Research Centre Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Sharma East India Hosp and Medical Research Ltd changed from ₹ 0.25 crore to ₹ 0.26 crore over 9 quarters. This represents a CAGR of 1.76% The Dividend Payout of Modern Diagnostic & Research Centre Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Sharma East India Hosp and Medical Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Modern Diagnostic & Research Centre Ltd

The Promoter, Mr. Devendra Singh Yadav started its operations of Diagnostic Centre in the name and style of 'Modern X-Ray and Clinical Lab' as Proprietorship firm in year 1985, which was later designated as 'Modern Diagnostic & Research Centre' in 1992.
Modern Diagnostic & Research Centre Limited was erstwhile incorporated as 'Modern Diagnostic & Research Centre Private Limited' as a private company, vide Certificate of Incorporation dated April 16, 2012 issued by Registrar of Companies, Delhi . Thereafter, the Company acquired the business of M/s.
Modern Diagnostics & Research Centre, a Proprietorship Concern through Business Transfer Agreement in 2013.
Subsequently, its status got converted from private limited into public limited and the name of the Company was changed to 'Modern Diagnostic & Research Centre Limited' pursuant to fresh certificate of incorporation dated December 18, 2024 issued by Registrar of Companies, Central Processing Centre.

About Sharma East India Hosp and Medical Research Ltd

Sharma East India Hospitals & Medical Research Limited was incorporated on November 16, 1989.
The Company is engaged in providing medical and healthcare services and real estate services and is presently running a multi-specialty hospital in the name of 'Jaipur Hospital' at Lal Kothi, at Rajasthan since 1989. As far as the achievements of the Company are concerned, the first assessment of the Company was conducted by National Accreditation Board for Hospitals and Health Care Providers (NABH), NABH accreditation system is one of the methods for commitment to quality enhancement throughout whole of the health care system in India.
It involves all professional and service groups to ensure that high quality in health care is achieved, while minimizing the inherent risks associated with modern health care delivery.

FAQs for the comparison of Modern Diagnostic & Research Centre Ltd and Sharma East India Hosp and Medical Research Ltd

Which company has a larger market capitalization, Modern Diagnostic & Research Centre Ltd or Sharma East India Hosp and Medical Research Ltd?

Market cap of Modern Diagnostic & Research Centre Ltd is 90 Cr while Market cap of Sharma East India Hosp and Medical Research Ltd is 25 Cr

What are the key factors driving the stock performance of Modern Diagnostic & Research Centre Ltd and Sharma East India Hosp and Medical Research Ltd?

The stock performance of Modern Diagnostic & Research Centre Ltd and Sharma East India Hosp and Medical Research Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Modern Diagnostic & Research Centre Ltd and Sharma East India Hosp and Medical Research Ltd?

As of October 25, 2026, the Modern Diagnostic & Research Centre Ltd stock price is INR ₹60.0. On the other hand, Sharma East India Hosp and Medical Research Ltd stock price is INR ₹79.15.

How do dividend payouts of Modern Diagnostic & Research Centre Ltd and Sharma East India Hosp and Medical Research Ltd compare?

To compare the dividend payouts of Modern Diagnostic & Research Centre Ltd and Sharma East India Hosp and Medical Research Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.